State Street Corp Sarepta Therapeutics, Inc. Transaction History
State Street Corp
- $2.59 Trillion
- Q2 2025
A detailed history of State Street Corp transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, State Street Corp holds 4,695,027 shares of SRPT stock, worth $85.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,695,027
Previous 4,068,472
15.4%
Holding current value
$85.8 Million
Previous $260 Million
69.08%
% of portfolio
0.0%
Previous 0.01%
Shares
22 transactions
Others Institutions Holding SRPT
# of Institutions
463Shares Held
83.3MCall Options Held
5.6MPut Options Held
4.19M-
Black Rock Inc. New York, NY10.3MShares$189 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.16MShares$167 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY4.48MShares$81.8 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA2.53MShares$46.2 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.24MShares$41 Million0.01% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $1.6B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...